149 related articles for article (PubMed ID: 33090202)
21. A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk.
Yang JR; Cheng CY; Chen CY; Lin CH; Kuo CY; Huang HY; Wu FT; Yang YC; Wu CY; Liu MT; Hsiao PW
Antiviral Res; 2017 Apr; 140():62-75. PubMed ID: 28093338
[TBL] [Abstract][Full Text] [Related]
22. Antibody responses after inactivated influenza vaccine in young children.
Wright PF; Sannella E; Shi JR; Zhu Y; Ikizler MR; Edwards KM
Pediatr Infect Dis J; 2008 Nov; 27(11):1004-8. PubMed ID: 18833023
[TBL] [Abstract][Full Text] [Related]
23. Biphasic Waning of Hemagglutination Inhibition Antibody Titers After Influenza Vaccination in Children.
Xiong W; Tsang TK; Perera RAPM; Leung NHL; Fang VJ; Barr IG; Malik Peiris JS; Cowling BJ
J Infect Dis; 2022 Sep; 226(6):1022-1026. PubMed ID: 35380689
[TBL] [Abstract][Full Text] [Related]
24. Antibody-dependent cell-mediated cytotoxicity antibody responses to inactivated and live-attenuated influenza vaccination in children during 2014-15.
Florek K; Mutschler J; McLean HQ; King JP; Flannery B; Belongia EA; Friedrich TC
Vaccine; 2020 Feb; 38(8):2088-2094. PubMed ID: 31753674
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Human H3N2 Antibody Responses Elicited by Egg-Based, Cell-Based, and Recombinant Protein-Based Influenza Vaccines During the 2017-2018 Season.
Gouma S; Zost SJ; Parkhouse K; Branche A; Topham DJ; Cobey S; Hensley SE
Clin Infect Dis; 2020 Sep; 71(6):1447-1453. PubMed ID: 31598646
[TBL] [Abstract][Full Text] [Related]
26. Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50-80 years of age.
Ross TM; Lin CJ; Nowalk MP; Huang HH; Spencer SM; Shay DK; Sambhara S; Sundaram ME; Friedrich T; Sauereisen S; Bloom CE; Zimmerman RK
Hum Vaccin Immunother; 2014; 10(5):1195-203. PubMed ID: 24614078
[TBL] [Abstract][Full Text] [Related]
27. Characterising antibody kinetics from multiple influenza infection and vaccination events in ferrets.
Hay JA; Laurie K; White M; Riley S
PLoS Comput Biol; 2019 Aug; 15(8):e1007294. PubMed ID: 31425503
[TBL] [Abstract][Full Text] [Related]
28. A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adults.
Williams KV; Zhai B; Alcorn JF; Patricia Nowalk M; Levine MZ; Kim SS; Flannery B; Moehling Geffel K; Jaber Merranko A; Nagg JP; Collins M; Susick M; Clarke KS; Zimmerman RK; Martin JM
Vaccine; 2022 Jan; 40(5):780-788. PubMed ID: 34952751
[TBL] [Abstract][Full Text] [Related]
29. Immunological persistence of a seasonal influenza vaccine in people more than 3 years old.
Bai Y; Shi N; Lu Q; Yang L; Wang Z; Li L; Han H; Zheng D; Luo F; Zhang Z; Ai X
Hum Vaccin Immunother; 2015; 11(7):1648-53. PubMed ID: 26083828
[TBL] [Abstract][Full Text] [Related]
30. The effect of age and recent influenza vaccination history on the immunogenicity and efficacy of 2009-10 seasonal trivalent inactivated influenza vaccination in children.
Ng S; Ip DK; Fang VJ; Chan KH; Chiu SS; Leung GM; Peiris JS; Cowling BJ
PLoS One; 2013; 8(3):e59077. PubMed ID: 23554974
[TBL] [Abstract][Full Text] [Related]
31. Early Changes in Interferon Gene Expression and Antibody Responses Following Influenza Vaccination in Pregnant Women.
Giacomelli Cao R; Christian L; Xu Z; Jaramillo L; Smith B; Karlsson EA; Schultz-Cherry S; Mejias A; Ramilo O
J Infect Dis; 2022 Jan; 225(2):341-351. PubMed ID: 34197595
[TBL] [Abstract][Full Text] [Related]
32. Preexisting Immunity, Not Frailty Phenotype, Predicts Influenza Postvaccination Titers among Older Veterans.
Van Epps P; Tumpey T; Pearce MB; Golding H; Higgins P; Hornick T; Burant C; Wilson BM; Banks R; Gravenstein S; Canaday DH
Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28100496
[TBL] [Abstract][Full Text] [Related]
33. Antibodies Against Egg- and Cell-Grown Influenza A(H3N2) Viruses in Adults Hospitalized During the 2017-2018 Influenza Season.
Levine MZ; Martin ET; Petrie JG; Lauring AS; Holiday C; Jefferson S; Fitzsimmons WJ; Johnson E; Ferdinands JM; Monto AS
J Infect Dis; 2019 May; 219(12):1904-1912. PubMed ID: 30721982
[TBL] [Abstract][Full Text] [Related]
34. Trivalent influenza vaccine-induced antibody response to circulating influenza a (H3N2) viruses in 2010/11 and 2011/12 seasons.
Hiroi S; Morikawa S; Nakata K; Maeda A; Kanno T; Irie S; Ohfuji S; Hirota Y; Kase T
Hum Vaccin Immunother; 2015; 11(2):386-90. PubMed ID: 25692378
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the Hemagglutination Inhibition Titers against Influenza Vaccine Strains in Japan from the 2017/2018 to 2021/2022 Seasons Using a Single Set of Serum Samples.
Otani N; Nakajima K; Ishikawa K; Ichiki K; Yoda Y; Ueda T; Takesue Y; Yamamoto T; Tanimura S; Shima M; Okuno T
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891435
[TBL] [Abstract][Full Text] [Related]
36. The Effect of Influenza Vaccination History on Changes in Hemagglutination Inhibition Titers After Receipt of the 2015-2016 Influenza Vaccine in Older Adults in Hong Kong.
Ng TWY; Perera RAPM; Fang VJ; Yau EM; Peiris JSM; Tam YH; Cowling BJ
J Infect Dis; 2020 Jan; 221(1):33-41. PubMed ID: 31282541
[TBL] [Abstract][Full Text] [Related]
37. Comparison of A(H3N2) Neutralizing Antibody Responses Elicited by 2018-2019 Season Quadrivalent Influenza Vaccines Derived from Eggs, Cells, and Recombinant Hemagglutinin.
Wang W; Alvarado-Facundo E; Vassell R; Collins L; Colombo RE; Ganesan A; Geaney C; Hrncir D; Lalani T; Markelz AE; Maves RC; McClenathan B; Mende K; Richard SA; Schofield C; Seshadri S; Spooner C; Utz GC; Warkentien TE; Levine M; Coles CL; Burgess TH; Eichelberger M; Weiss CD
Clin Infect Dis; 2021 Dec; 73(11):e4312-e4320. PubMed ID: 32898271
[TBL] [Abstract][Full Text] [Related]
38. Heterologous Antibody Responses Conferred by A(H3N2) Variant and Seasonal Influenza Vaccination Against Newly Emerged 2016-2018 A(H3N2) Variant Viruses in Healthy Persons.
Liu F; Levine MZ
Clin Infect Dis; 2020 Dec; 71(12):3061-3070. PubMed ID: 31858129
[TBL] [Abstract][Full Text] [Related]
39. Serologic response to sequential vaccination with enhanced influenza vaccines: Open label randomized trial among adults aged 65-74 years.
McLean HQ; Levine MZ; King JP; Flannery B; Belongia EA
Vaccine; 2021 Dec; 39(49):7146-7152. PubMed ID: 34774360
[TBL] [Abstract][Full Text] [Related]
40. Immune Responses to Twice-Annual Influenza Vaccination in Older Adults in Hong Kong.
Tam YH; Valkenburg SA; Perera RAPM; Wong JHF; Fang VJ; Ng TWY; Kwong ASK; Tsui WWS; Ip DKM; Poon LLM; Chau CKV; Barr IG; Peiris JSM; Cowling BJ
Clin Infect Dis; 2018 Mar; 66(6):904-912. PubMed ID: 29069368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
